" class="no-js "lang="en-US"> Thierry Chauche - Medtech Alert
Thursday, March 30, 2023

Breaking News

Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Implantica Launches RefluxStop™ in Italy Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases Xeris Biopharma Appoints Ricki Fairley to Board of Directors AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson’s Disease New Imaging Method for Evaluating Transport of Oxygen to Blood Cells
Thierry Chauche

Thierry Chauche

About Thierry Chauche

Aspiring CFO with ~20 years of experience in Finance and Healthcare (Alexion Pharmaceuticals, Intercept Pharmaceuticals and Novartis in FP&A and Rothschild in Mergers & Acquisitions).
Strategic and creative thinker, results oriented, with strong leadership and business-partnering skills.
Change leader experienced in managing complexity (organization and projects) and ambiguity.
Passionate team builder and talent developer.

Related Story

Appointments

 Provention Bio Announces Appointment of Thierry Chauche as Chief Financial Officer | Pharmtech Focus

Provention Bio Announces Appointment of Thierry Chauche as Chief Financial Officer

November 4 2021

Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today […]